Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Clovis Oncology Inc

+ Add to Watchlist

CLVS:US

82.8100 USD 4.1900 4.82%

As of 17:20:00 ET on 06/02/2015.

Company Profile for Clovis Oncology Inc (CLVS)

Clovis Oncology Inc. is a biopharmaceutical company. The Company is focused on acquiring, developing and commercializing innovative anti-cancer agents in the United States, Europe and additional international markets. Clovis target its development programs for the treatment of specific subsets of cancer populations.

Contact Information

Clovis Oncology Inc

2525 28th Street
Suite 100
Boulder, CO 80301
United States
Phone: 1-303-625-5000

Key Executives for Clovis Oncology Inc (CLVS)

Patrick J MahaffyPresident/CEO/Co-FounderErle T MastExec VP/CFO/Secy/Co-Founder
Steven L HoerterExec VP/Chief Commercial OfcrAndrew R AllenExec VP:PRE-Clinical Dev

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil